Archives

  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br Thanapprapasr D Deesamer S Sujintawong S Udomsubpayakul

    2022-05-06


    [5] Thanapprapasr D, Deesamer S, Sujintawong S, Udomsubpayakul U, Wilailak S. Cervical cancer screening behaviours among Thai women: results from a cross-sectional survey of 2112 healthcare providers at Ramathibodi Hospital, Thailand. Eur J Cancer Care (Engl) 2012;21:542e7.
    [6] FDA Advisory Committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer [media release]. http://www.roche.com/media/media_releases/med-cor-2014-03-13.htm.
    [7] Darlin L, Borgfeldt C, Forslund O, Henic E, Hortlund M, Dillner J, et al. Com-parison of use of vaginal HPV self-sampling and offering flexible appoint-ments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol 2013;58:155e60. [8] Scarinci IC, Litton AG, Garces-Palacio IC, Partridge EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues 2013;23:e123e30.
    [9] Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009;16:193e8.
    [10] Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright Jr TC. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Women's Health (Larchmt) 2005;14:721e8.
    [11] Darlin L, Borgfeldt C, Forslund O, Henic E, Dillner J, Kannisto P. Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity. J Clin Virol 2013;56:52e6. [12] Wu R, Du H, Belinson SE, Pretorius RG, Zou J, Yang B, et al. Secondary screening after primary self-sampling for human papillomavirus from SHENCCAST II. J Low Genit Tract Dis 2012;16:416e20.
    [13] Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and gamma-Glu-Cys for cervical can-cer screening in developing countries? Cancer Epidemiol 2009;33: 446e50.
    [15] Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papilloma-virus and liquid based cervical cytology. Int J Gynecol Cancer 2003;13: 819e26.
    [16] Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, et al. HPV Self-collection Guidelines Panel. Self-collected samples for testing of onco-genic human papillomavirus: a systematic review. J Obstet Gynaecol Can 2007;29:817e28.
    [17] Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Ac-curacy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172e83.
    [18] Sancho-Garnierr H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cer-vical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013;133:2681e7.
    [19] Haguenoer K, Giraudeau B, Gaudy-Grsffin C, de-Pinieux I, Dubois F, Trignol-Viguier N, et al. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study. Gynecol Oncol 2014;134:302e8.
    [20] Untiet S, Vassilakos P, McCarey C, Tebeu PM, Kengne-Fosso G, Menoud PA, et al. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int J Cancer 2014;135:1911e7. [21] Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet 2014;126:156e60.
    [22] Canda MT, Demir N, Sezer O, Doganay L, Ortac R. Clinical results of the liquid-based cervical cytology tool, Liqui-PREP, in comparison with conventional smears for detection of squamous cell abnormalities. Asian Pac J Cancer Prev 2009;10:399e402.
    [23] Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cer-vical cancer risk for women undergoing concurrent testing for human
    papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 2011;12:663e72. [24] Oranratanaphan S, Termrungruanglert W, Khemapech N. Acceptability of self-sampling HPV testing among Thai women for cervical cancer screening. Asian Pac J Cancer Prev 2014;15:7437e41.
    [27] Chang CC, Tseng CJ, Liu WW, Jain S, Horng SG, Soong YK, et al. Clinical eval-uation of a new model of self-obtained method for the assessment of genital human papilloma virus infection in an underserved population. Chang Gung Med J 2002;25:664e71.